Oncology Enrollment Enhancement

Your first patient in, faster

Oncology research presents a challenge to drug developers, with 60 percent of sites never enrolling a single patient. PPD uses a just-in-time methodology to jump-start study enrollment, augmenting traditional enrollment approaches to activate sites within 14 days of patient identification. This oncology enrollment enhancement solution leverages pre-identified patients from prequalified sites to provide first patient in, faster.

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.